Beschreibung:

NSABP PROTOCOL B-36: FOLLOW-UP FORM Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer NCT00087178 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C89314D7-1DBA-74BA-E034-0003BA12F5E7

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C89314D7-1DBA-74BA-E034-0003BA12F5E7
Stichworte:
Versionen (4)
  1. 26.08.12 26.08.12 -
  2. 09.01.15 09.01.15 - Martin Dugas
  3. 13.04.15 13.04.15 - Martin Dugas
  4. 20.09.21 20.09.21 -
Hochgeladen am:

20. September 2021

DOI:
Für eine Beantragung loggen Sie sich ein.
Lizenz :
Creative Commons BY-NC 3.0 Legacy
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Breast Cancer FOLLOW-UP NSABP B-36 NCT00087178

Englisch
Details

No Instruction available.

1 Formulare  
  1. StudyEvent: NSABP PROTOCOL B-36: FOLLOW-UP FORM
    1. No Instruction available.
Header
Are data amended (check box if yes, and circle amended items)
Vital Status
Patient's Vital Status
Source of Survival Information (if alive)
Primary cause of Death (if dead)
Was there evidence of recurrence at the time of death?
Cancer Follow-up Status
Has the patient had a documented clinical assessment for this cancer (since submission of the last follow-up form)?
First Local-regional Recurrence
Has the patient been diagnosed with first local-regional recurrence (since submission of the last follow-up form)?
Site(s) of First Local-Regional Recurrence (mark all ipsilateral sites that apply)
3 weitere Items in der Detailansicht.
First Distant Recurrence
Has the patient been diagnosed with first distant recurrence/progression (since submission of the last follow-up form)?
New Primary Cancer Or Mds
Has a new primary cancer or MDS been diagnosed that has not been previously reported?
Patient data
Has the patient had a menstrual period or vaginal bleeding in the last 12 months?
Has the patient had a hysterectomy?
Has the patient had a bilateral oophorectomy?
Was patient randomized to receive Celecoxib or Placebo?
Did the patient experience any of the following adverse events that have not been previously reported?
Adverse Events
Adverse Event
23 weitere Items in der Detailansicht.
Grade
Late Adverse Events
Has the patient experienced any severe (Grade >= 3) adverse event, possibly related to the chemotherapy, that has not been previously reported?
Therapy
Did the patient receive any Herceptin treatment (since randomization since last follow-up)
Did the patient receive any systemic hormonal treatment (since randomization since last follow-up)
Tamoxifen
Anastrozole
Exemestane
Letrozole
LHRH agonist
Other, specify
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video